Cecryon Europe will open the first European Center for human cryopreservation in Valencia
Written by Sandra Arteaga
Living as long as possible is the highest expectation of much of the human population. Death, however, continues to stalk while seeking the cure of numerous diseases for which, so far, no possible solution has been developed. As this occurs, it appears that the cryopreservation (or cryogenics) -The people freezing after death has become the only hope for after death, to return to life in the future.
Although there are some entities that offer this service in the United States, where there are hundreds of cryopreserved people, in Europe there was no company that offered this possibility. Now it will be the Valencian company cecryon that makes this service available to users throughout Europe. Directed by Javier Tapia, Cecryon has its center in Valencia, in facilities of 1,500 square meters that will be suitable to begin offering this alternative to burial or incineration at the end of 2019.
“This service has been offered in the United States for 50 years,” explains Tapia. The technique used will be vitrification, already used with ovules and embryos. It is a freezing process that prevents the formation of ice at very low temperatures by using an antifreeze gel that replaces the blood. This would prevent the death of brain cells, with the intention of returning the human body to life when the solution is found and the person’s health problems can be reversed.
A project supported by Demium Startups
“At eight I saw in a magazine my father an article crionica and I wanted to be a customer. I turned 30 and no European company offered the service. So I decided to create it to be a client myself and to offer it to others, ”explains Tapia. The project was born five years ago by reinforcing its intentions with the article ‘Arguments in favor of cryogenization‘ published by the Massachusetts Institute of Technology (MIT).
The team progressed in the project until they found Demium Startups, the business incubator led by Jorge Dobón, where they have developed their project since December. There are currently four people in the company – including a doctor – although they hope to incorporate a commercial director and a marketing specialist soon.
“We are the last line of defense of the life of the human being. When medicine fails, when the person is going to die, their only option is to bury or burn and with us they have a third, which is cryopreservation, ”says Tapia. “This is ethically important, because cryopreservation never replaces any proven medical treatment, but instead happens as soon as everything else has failed,” he insists.
A 100 year contract
“The person becomes guarded and guarded by Cecryon for as long as necessary until their technological or medical recovery is viable,” he says. Over the years that the frozen body can remain, it recognizes that the time that will pass until the possible recovery of the patient is difficult to predict.
After being advised for three years by the lawyer Pedro Gil, partner of Cuatrecasas, they decided that the legal framework should be that of a funeral home, although Tapia insists that for the company they are patients. Cecryon offers a contract for 100 years – although it is necessary to increase it if necessary. Tapia acknowledges that he hopes the person can be recovered “well before” if science continues with its advances as before.
There is no absolute guarantee.
It is clear that, despite advances that imply that science could recover a person, it is not possible to guarantee it and from Cecryon they emphasize this issue. “Offering absolute guarantees of recovery in one hundred percent of cases will prove impossible even when possible the recovery of cryopreserved patients ”, recognizes Tapia. To date, only small worms and animal organs have been successfully recovered , in addition to ovules and embryos , so it insists on the importance of influencing the experimental nature of these techniques.
On how they can maintain the facilities for so long, he points out that thanks to renewable energy it will be much cheaper to produce liquid nitrogen to keep the bodies frozen. “We hope that this reduction of costs will allow that within a few years keeping cryopreserved people does not cost practically money,” says the CEO of the company.
But is there a market? “The two companies that exist in the United States have hundreds of customers across Europe targeted at them, and they are our first early adopters . Moreover, they are still aware that it is impossible to move a body from the European Union to the United States without embalming, which chemically destroys the body. Despite that, they prefer to pay and try to get it out by negotiating with the corresponding authorities than stop paying, ”he says. The user profile of their service are people who have high purchasing power and are concerned with combating aging, in addition to transhumanists.
To qualify for the service there will be three forms of payment. On the one hand he will direct, will be the only available when it produ z c to service urgencia.Por other hand the customer can make a down payment of 40,000 euros and leave pledged 160,000 in the bank. “The money will be released when the death report is presented and the service certificate as a local funeral home,” he says.
Finally, thanks to an agreement with an important insurance company, it will offer the service through a life policy that will allow access to the service in an affordable way for those under 65. On the other hand, it stands out that the scalability of the model is simple thanks to the agreements that have reached with third companies to provide the service for Europe.
In investment round
They are currently closing a financing round of 330,000 euros, in order to allocate them to technological equipment and cover the first years of the company. A round of which at the moment they have already covered 75,000 euros.
What if a user wakes up in the future? From Cecryon they would take charge of the reintegration into society, assuming the costs that may arise from the process.